Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Bath & Body Works price target raised to $52 from $45 at Jefferies » 07:52
01/31/23
01/31
07:52
01/31/23
07:52
BBWI

Bath & Body Works

$44.06 /

-0.57 (-1.28%)

, COTY

Coty

$9.83 /

-0.03 (-0.30%)

, EL

Estee Lauder

$271.17 /

+0.38 (+0.14%)

, ULTA

Ulta Beauty

$507.88 /

+1.76 (+0.35%)

Jefferies analyst Ashley…

Jefferies analyst Ashley Helgans raised the firm's price target on Bath & Body Works (BBWI) to $52 from $45 and keeps a Buy rating on the shares ahead of December quarter reports and FY23 guidance form the Cosmetics, Household & Personal Care group. Given macro uncertainty, the firm expects "broadly conservative FY23 outlooks," but it sees select opportunities, calling out Coty (COTY), Estee Lauder (EL) and Ulta Beauty (ULTA) as remaining its top picks.

ShowHide Related Items >><<
ULTA Ulta Beauty
$507.88 /

+1.76 (+0.35%)

EL Estee Lauder
$271.17 /

+0.38 (+0.14%)

COTY Coty
$9.83 /

-0.03 (-0.30%)

BBWI Bath & Body Works
$44.06 /

-0.57 (-1.28%)

BBWI Bath & Body Works
$44.06 /

-0.57 (-1.28%)

01/06/23 Wells Fargo
Bath & Body Works downgraded to Equal Weight from Overweight at Wells Fargo
01/06/23 Wells Fargo
Bath & Body Works downgraded to Equal Weight from Overweight at Wells Fargo
01/03/23 JPMorgan
Bath & Body Works price target raised to $43 from $40 at JPMorgan
01/03/23 Piper Sandler
Bath & Body Works price target raised to $52 from $50 at Piper Sandler
COTY Coty
$9.83 /

-0.03 (-0.30%)

01/13/23 JPMorgan
Coty price target raised to $9 from $8 at JPMorgan
01/03/23 Piper Sandler
Coty upgraded to Overweight from Neutral at Piper Sandler
12/06/22 Deutsche Bank
Coty price target raised to $11 from $10 at Deutsche Bank
10/24/22 Deutsche Bank
Coty price target lowered to $10 from $11 at Deutsche Bank
EL Estee Lauder
$271.17 /

+0.38 (+0.14%)

01/24/23 Stifel
Estee Lauder price target raised to $295 from $255 at Stifel
01/23/23 Deutsche Bank
Estee Lauder price target raised to $290 from $266 at Deutsche Bank
01/17/23 Oppenheimer
Estee Lauder price target raised to $300 from $245 at Oppenheimer
01/13/23 JPMorgan
Estee Lauder price target raised to $285 from $274 at JPMorgan
ULTA Ulta Beauty
$507.88 /

+1.76 (+0.35%)

01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/05/23 Argus
Ulta Beauty price target raised to $530 from $455 at Argus
12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
ULTA Ulta Beauty
$507.88 /

+1.76 (+0.35%)

EL Estee Lauder
$271.17 /

+0.38 (+0.14%)

COTY Coty
$9.83 /

-0.03 (-0.30%)

BBWI Bath & Body Works
$44.06 /

-0.57 (-1.28%)

ULTA Ulta Beauty
$507.88 /

+1.76 (+0.35%)

EL Estee Lauder
$271.17 /

+0.38 (+0.14%)

COTY Coty
$9.83 /

-0.03 (-0.30%)

ULTA Ulta Beauty
$507.88 /

+1.76 (+0.35%)

EL Estee Lauder
$271.17 /

+0.38 (+0.14%)

COTY Coty
$9.83 /

-0.03 (-0.30%)

BBWI Bath & Body Works
$44.06 /

-0.57 (-1.28%)

ULTA Ulta Beauty
$507.88 /

+1.76 (+0.35%)

EL Estee Lauder
$271.17 /

+0.38 (+0.14%)

COTY Coty
$9.83 /

-0.03 (-0.30%)

BBWI Bath & Body Works
$44.06 /

-0.57 (-1.28%)

Over a week ago
Periodicals
Conagra doesn't see need for 'big' price hikes in 2023, WSJ says » 17:51
01/12/23
01/12
17:51
01/12/23
17:51
CAG

Conagra Brands

$40.13 /

-0.39 (-0.96%)

, CMG

Chipotle

$1,512.34 /

+38.3 (+2.60%)

, ULTA

Ulta Beauty

$491.55 /

-1.6802 (-0.34%)

Conagra (CAG) does not…

Conagra (CAG) does not intend to hike prices in 2023, depending on the future path of inflation this year, Chief Financial Officer David Marberger said, according to Jennifer Williams-Alvarez, writing for the Wall Street Journal. Conagra, maker of Hunt's ketchup, Healthy Choice frozen meals and Slim Jim meat sticks, said even if inflation continues," and we take "any pricing, any adjustments would be moderate," according to the WSJ story. "Companies including burrito chain Chipotle Mexican Grill (CMG) and beauty products maker Ulta Beauty (ULTA). last year raised prices to combat higher costs, including for wages and raw materials." noted the WSJ. Reference Link

ShowHide Related Items >><<
ULTA Ulta Beauty
$491.55 /

-1.6802 (-0.34%)

CMG Chipotle
$1,512.34 /

+38.3 (+2.60%)

CAG Conagra Brands
$40.13 /

-0.39 (-0.96%)

CAG Conagra Brands
$40.13 /

-0.39 (-0.96%)

01/06/23 RBC Capital
Conagra Brands price target raised to $38 from $35 at RBC Capital
01/06/23 Stifel
Conagra Brands price target raised to $44 from $35 at Stifel
12/29/22 Evercore ISI
Conagra Brands price target raised to $42 from $40 at Evercore ISI
12/20/22 Morgan Stanley
Conagra Brands upgraded to Overweight at Morgan Stanley on defensive positioning
CMG Chipotle
$1,512.34 /

+38.3 (+2.60%)

01/05/23 Barclays
Chipotle price target lowered to $1,450 from $1,510 at Barclays
10/27/22 Deutsche Bank
Chipotle price target lowered to $1,699 from $1,708 at Deutsche Bank
10/26/22 Stephens
Chipotle price target lowered to $1,760 from $1,900 at Stephens
10/26/22 KeyBanc
Chipotle price target raised to $1,800 from $1,750 at KeyBanc
ULTA Ulta Beauty
$491.55 /

-1.6802 (-0.34%)

01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/05/23 Argus
Ulta Beauty price target raised to $530 from $455 at Argus
12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
ULTA Ulta Beauty
$491.55 /

-1.6802 (-0.34%)

CMG Chipotle
$1,512.34 /

+38.3 (+2.60%)

CAG Conagra Brands
$40.13 /

-0.39 (-0.96%)

CMG Chipotle
$1,512.34 /

+38.3 (+2.60%)

CAG Conagra Brands
$40.13 /

-0.39 (-0.96%)

ULTA Ulta Beauty
$491.55 /

-1.6802 (-0.34%)

CMG Chipotle
$1,512.34 /

+38.3 (+2.60%)

CAG Conagra Brands
$40.13 /

-0.39 (-0.96%)

ULTA Ulta Beauty
$491.55 /

-1.6802 (-0.34%)

CMG Chipotle
$1,512.34 /

+38.3 (+2.60%)

CAG Conagra Brands
$40.13 /

-0.39 (-0.96%)

On The Fly
What You Missed On Wall Street On Friday » 16:33
01/06/23
01/06
16:33
01/06/23
16:33
LUV

Southwest

$35.09 /

+1.56 (+4.65%)

, BAX

Baxter

$48.46 /

-4.1 (-7.80%)

, WWE

WWE

$84.15 /

+12.1 (+16.79%)

, MCD

McDonald's

$269.57 /

+7.4 (+2.82%)

, BIIB

Biogen

$279.39 /

+7.84 (+2.89%)

, ESALY

Eisai

$64.20 /

+2.53 (+4.10%)

, JPM

JPMorgan

$137.93 /

+2.57 (+1.90%)

, BAC

Bank of America

$34.42 /

+0.355 (+1.04%)

, LULU

Lululemon

$329.32 /

+3.385 (+1.04%)

, ALGS

Aligos Therapeutics

$1.29 /

+0.2974 (+29.96%)

, ULTA

Ulta Beauty

$486.31 /

-2.83 (-0.58%)

, SI

Silvergate Capital

$12.22 /

-0.34 (-2.71%)

, TSLA

Tesla

$113.01 /

+2.635 (+2.39%)

, LAZR

Luminar

$3.95 /

-0.385 (-8.89%)

, BZLFY

Bunzl

$35.00 /

+1.01 (+2.97%)

, RTX

Raytheon Technologies

$102.45 /

+1.58 (+1.57%)

, PFE

Pfizer

$50.91 /

+1.2548 (+2.53%)

, AEHR

Aehr Test Systems

$22.80 /

+5.555 (+32.21%)

, AMRN

Amarin

$1.45 /

+0.195 (+15.60%)

, FATE

Fate Therapeutics

$4.24 /

-6.725 (-61.33%)

, JNJ

Johnson & Johnson

$180.25 /

+1.46 (+0.82%)

, ATAI

Atai Life Sciences

$1.80 /

-0.845 (-32.01%)

, XPEV

XPeng

$10.10 /

-1.8 (-15.13%)

, BOOT

Boot Barn

$61.98 /

-0.945 (-1.50%)

, HTGM

HTG Molecular

$3.32 /

-0.35 (-9.54%)

, GBX

Greenbrier

$28.67 /

-6.23 (-17.85%)

, AUPH

Aurinia Pharmaceuticals

$7.55 /

+0.675 (+9.82%)

, SSNLF

Samsung

$40.60 /

+ (+0.00%)

Get caught up quickly on…

ShowHide Related Items >><<
XPEV XPeng
$10.10 /

-1.8 (-15.13%)

WWE WWE
$84.15 /

+12.1 (+16.79%)

ULTA Ulta Beauty
$486.31 /

-2.83 (-0.58%)

TSLA Tesla
$113.01 /

+2.635 (+2.39%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$12.22 /

-0.34 (-2.71%)

RTX Raytheon Technologies
$102.45 /

+1.58 (+1.57%)

PFE Pfizer
$50.91 /

+1.2548 (+2.53%)

MCD McDonald's
$269.57 /

+7.4 (+2.82%)

LUV Southwest
$35.09 /

+1.56 (+4.65%)

LULU Lululemon
$329.32 /

+3.385 (+1.04%)

LAZR Luminar
$3.95 /

-0.385 (-8.89%)

JPM JPMorgan
$137.93 /

+2.57 (+1.90%)

JNJ Johnson & Johnson
$180.25 /

+1.46 (+0.82%)

HTGM HTG Molecular
$3.32 /

-0.35 (-9.54%)

GBX Greenbrier
$28.67 /

-6.23 (-17.85%)

FATE Fate Therapeutics
$4.24 /

-6.725 (-61.33%)

ESALY Eisai
$64.20 /

+2.53 (+4.10%)

BOOT Boot Barn
$61.98 /

-0.945 (-1.50%)

BIIB Biogen
$279.39 /

+7.84 (+2.89%)

BAX Baxter
$48.46 /

-4.1 (-7.80%)

BAC Bank of America
$34.42 /

+0.355 (+1.04%)

AUPH Aurinia Pharmaceuticals
$7.55 /

+0.675 (+9.82%)

ATAI Atai Life Sciences
$1.80 /

-0.845 (-32.01%)

AMRN Amarin
$1.45 /

+0.195 (+15.60%)

ALGS Aligos Therapeutics
$1.29 /

+0.2974 (+29.96%)

AEHR Aehr Test Systems
$22.80 /

+5.555 (+32.21%)

LUV Southwest
$35.09 /

+1.56 (+4.65%)

12/16/22 Goldman Sachs
Southwest resumed with a Neutral at Goldman Sachs
12/15/22 Cowen
Copa Holdings upgraded to Outperform at Cowen amid airlines rating shake-up
12/08/22 Susquehanna
Southwest guidance suggests risk around order book, says Susquehanna
12/08/22 Deutsche Bank
Southwest price target raised to $62 from $60 at Deutsche Bank
BAX Baxter
$48.46 /

-4.1 (-7.80%)

01/06/23 Morgan Stanley
Baxter downgraded to Equal Weight from Overweight at Morgan Stanley
01/05/23 Raymond James
Baxter downgraded to Market Perform from Outperform at Raymond James
01/04/23 Barclays
Baxter price target lowered to $63 from $64 at Barclays
01/03/23 BofA
BofA downgrades Baxter to Neutral, prefers Becton Dickinson
WWE WWE
$84.15 /

+12.1 (+16.79%)

01/06/23 Loop Capital
WWE price target raised to $105 from $90 at Loop Capital
01/06/23 MKM Partners
MKM Partners sees WWE as 'very attractive asset' if it goes for sale
11/29/22 Morgan Stanley
WWE price target raised to $80 from $75 at Morgan Stanley
10/19/22 MKM Partners
WWE price target raised to $90 from $84 at MKM Partners
MCD McDonald's
$269.57 /

+7.4 (+2.82%)

01/05/23 Oppenheimer
Oppenheimer downgrades Wendy's, reveals top 2023 restaurant picks
01/05/23 Deutsche Bank
McDonald's price target raised to $263 from $262 at Deutsche Bank
01/05/23 Barclays
McDonald's price target raised to $310 from $295 at Barclays
12/21/22 Jefferies
McDonald's price target raised to $315 from $305 at Jefferies
BIIB Biogen
$279.39 /

+7.84 (+2.89%)

01/05/23 RBC Capital
RBC says hotline sign of possible imminent approval for Biogen
12/02/22 JonesResearch
Anavex price target raised to $80 from $40 at JonesTrading
12/01/22 Atlantic Equities
Biogen price target raised to $295 from $220 at Atlantic Equities
11/30/22 Mizuho
Mizuho says Biogen not mentioned in 90 minute lecanemab presentation
ESALY Eisai
$64.20 /

+2.53 (+4.10%)

11/30/22 Jefferies
Biogen price target raised to $350 from $325 at Jefferies
11/29/22 Jefferies
Prothena data from AD/PD abstract 'promising,' says Jefferies
JPM JPMorgan
$137.93 /

+2.57 (+1.90%)

01/06/23 Deutsche Bank
JPMorgan downgraded to Hold with $145 target at Deutsche Bank
01/06/23 Deutsche Bank
JPMorgan downgraded to Hold from Buy at Deutsche Bank
01/03/23 Barclays
JPMorgan price target raised to $189 from $162 at Barclays
12/28/22 Oppenheimer
JPMorgan price target lowered to $169 from $174 at Oppenheimer
BAC Bank of America
$34.42 /

+0.355 (+1.04%)

01/06/23 Deutsche Bank
Bank of America downgraded to Hold with $36 target at Deutsche Bank
01/06/23 Deutsche Bank
Bank of America downgraded to Hold from Buy at Deutsche Bank
01/03/23 Barclays
Bank of America price target lowered to $48 from $51 at Barclays
12/28/22 Oppenheimer
Bank of America price target lowered to $51 from $52 at Oppenheimer
LULU Lululemon
$329.32 /

+3.385 (+1.04%)

01/06/23 Wells Fargo
Lululemon upgraded to Overweight from Equal Weight at Wells Fargo
01/06/23 Wells Fargo
Lululemon upgraded to Overweight from Equal Weight at Wells Fargo
01/05/23 Piper Sandler
Lululemon price target lowered to $385 from $390 at Piper Sandler
12/12/22 Argus
Lululemon selloff presents buying opportunity, says Argus
ALGS Aligos Therapeutics
$1.29 /

+0.2974 (+29.96%)

01/06/23 Piper Sandler
Aligos upgraded to Overweight at Piper after peer's 'highly encouraging' data
01/06/23 Piper Sandler
Aligos Therapeutics upgraded to Overweight from Neutral at Piper Sandler
01/06/23 Jefferies
Jefferies upgrades Aligos to Buy on derisking of NASH pill
01/06/23 Jefferies
Aligos Therapeutics upgraded to Buy from Hold at Jefferies
ULTA Ulta Beauty
$486.31 /

-2.83 (-0.58%)

01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/05/23 Argus
Ulta Beauty price target raised to $530 from $455 at Argus
12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
SI Silvergate Capital
$12.22 /

-0.34 (-2.71%)

01/06/23 Craig-Hallum
Silvergate Capital downgraded to Hold from Buy at Craig-Hallum
01/06/23 BofA
BofA downgrades Silvergate to Underperform with 'more questions than answers'
01/06/23 BofA
Silvergate Capital downgraded to Underperform from Neutral at BofA
01/06/23 Canaccord
Silvergate Capital price target lowered to $25 from $150 at Canaccord
TSLA Tesla
$113.01 /

+2.635 (+2.39%)

01/06/23 Piper Sandler
Piper 'unsurprised' by Tesla decision to cut prices in China
01/06/23 BofA
XPeng downgraded to Neutral at BofA after Tesla price cuts
01/06/23 GLJ Research
Tesla price cuts in China 'much worse than you think,' says GLJ Research
01/05/23 Edward Jones
Edward Jones upgrades Tesla on long-term growth opportunities
LAZR Luminar
$3.95 /

-0.385 (-8.89%)

12/20/22 JPMorgan
Luminar price target lowered to $16 from $30 at JPMorgan
12/07/22 Citi
Luminar price target lowered to $20 from $21 at Citi
11/16/22 Berenberg
Berenberg says top LiDAR idea Innoviz Technologies undervalued
11/01/22 WestPark Capital
Luminar initiated with a Buy at WestPark Capital
BZLFY Bunzl
$35.00 /

+1.01 (+2.97%)

12/16/22 Barclays
Bunzl downgraded to Underweight from Equal Weight at Barclays
11/14/22 Credit Suisse
Bunzl assumed with a Neutral at Credit Suisse
08/31/22 JPMorgan
Bunzl price target raised to 3,250 GBp from 3,200 GBp at JPMorgan
08/19/22 Jefferies
Bunzl downgraded to Hold from Buy at Jefferies
RTX Raytheon Technologies
$102.45 /

+1.58 (+1.57%)

12/08/22 Citi
Raytheon Technologies initiated with a Neutral at Citi
11/28/22 Cowen
Raytheon Technologies a Best Idea for 2023, says Cowen
10/26/22 Morgan Stanley
Raytheon Technologies price target lowered to $119 from $124 at Morgan Stanley
10/26/22 Baird
Raytheon Technologies price target lowered to $106 from $117 at Baird
PFE Pfizer
$50.91 /

+1.2548 (+2.53%)

01/05/23 Morgan Stanley
Morgan Stanley sees Moderna's phase 3 RSV vaccine data as catalyst-driven idea
01/04/23 BofA
BioMarin price target raised to $200, added to 'US 1 List' at BofA
01/04/23 BofA
Pfizer downgraded to Neutral at BofA on COVID-19 uncertainty
01/04/23 BofA
Pfizer downgraded to Neutral from Buy at BofA
AEHR Aehr Test Systems
$22.80 /

+5.555 (+32.21%)

10/17/22 William Blair
Aehr Test Systems initiated with an Outperform at William Blair
AMRN Amarin
$1.45 /

+0.195 (+15.60%)

01/06/23 Jefferies
Jefferies upgrades 'intriguing small cap value play' Amarin to Buy
01/06/23 Jefferies
Amarin upgraded to Buy from Hold at Jefferies
05/06/22 JPMorgan
JPMorgan downgrades Amarin to sell on headwinds in U.S., Europe
05/06/22 JPMorgan
Amarin downgraded to Underweight from Neutral at JPMorgan
FATE Fate Therapeutics
$4.24 /

-6.725 (-61.33%)

01/06/23 Truist
Truist cuts Fate Therapeutics to Hold after discontinuing Janssen collaboration
01/06/23 BofA
Fate Therapeutics double downgraded to Underperform at BofA
01/06/23 BofA
Fate Therapeutics downgraded to Underperform from Buy at BofA
01/06/23 Wedbush
Fate Therapeutics downgraded to Neutral from Outperform at Wedbush
JNJ Johnson & Johnson
$180.25 /

+1.46 (+0.82%)

01/06/23 BMO Capital
Fate Therapeutics downgraded to Market Perform from Outperform at BMO Capital
01/03/23 Wells Fargo
Wells Fargo upgrades Immunovant to Overweight, raises price target to $27
ATAI Atai Life Sciences
$1.80 /

-0.845 (-32.01%)

01/06/23 EF Hutton
Atai Life Sciences price target lowered to $15 from $23 at EF Hutton
12/15/22 EF Hutton
Atai Life Sciences initiated with a Buy at EF Hutton
11/01/22 Loop Capital
Atai Life Sciences initiated with a Buy at Loop Capital
09/01/22 Citi
Atai Life Sciences price target lowered to $20 from $22 at Citi
XPEV XPeng
$10.10 /

-1.8 (-15.13%)

01/06/23 BofA
XPeng downgraded to Neutral from Buy at BofA
01/04/23 Wedbush
Demand issues, Twitter focus creates 'perfect storm' for Tesla, says Wedbush
12/14/22 Daiwa
Daiwa downgrades XPeng to Sell from Buy on 'weakened competitiveness'
BOOT Boot Barn
$61.98 /

-0.945 (-1.50%)

01/06/23 BofA
Boot Barn initiated with a Buy, $85 price target at BofA
01/06/23 BofA
Boot Barn initiated with a Buy at BofA
01/04/23 Citi
Citi ups Boot Barn target, expects positive preannouncement
01/03/23 JPMorgan
Boot Barn price target raised to $94 from $92 at JPMorgan
HTGM HTG Molecular
$3.32 /

-0.35 (-9.54%)

12/29/22 H.C. Wainwright
H.C. Wainwright institutes $15 price target on HTG Molecular shares
07/22/22 Cantor Fitzgerald
HTG Molecular price target lowered to $3.50 from $15 at Cantor Fitzgerald
05/16/22 H.C. Wainwright
HTG Molecular price target lowered to $3 from $4 at H.C. Wainwright
03/30/22 H.C. Wainwright
HTG Molecular price target lowered to $4 from $9 at H.C. Wainwright
GBX Greenbrier
$28.67 /

-6.23 (-17.85%)

11/07/22 Susquehanna
Greenbrier downgraded to Neutral from Positive at Susquehanna
07/13/22 Cowen
Greenbrier price target lowered to $47 from $54
07/12/22 Susquehanna
Greenbrier price target lowered to $38 from $58 at Susquehanna
07/11/22 BofA
Greenbrier downgraded to Neutral at BofA after Q3 earnings miss
AUPH Aurinia Pharmaceuticals
$7.55 /

+0.675 (+9.82%)

01/03/23 RBC Capital
Aurinia price target raised to $11 from $10 at RBC Capital
11/07/22 H.C. Wainwright
Aurinia Pharmaceuticals price target lowered to $14 from $26 at H.C. Wainwright
11/04/22 Oppenheimer
Oppenheimer downgrades Aurinia on commercial challenges
11/04/22 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
SSNLF Samsung
$40.60 /

+ (+0.00%)

11/25/22 William Blair
Report about Galaxy S23 'significant positive' for Iridium, says William Blair
08/22/22 Loop Capital
Enovix price target raised to $100 from $50 at Loop Capital
08/11/22 Loop Capital
Loop Capital has 'stronger conviction' in Enovix after 'customer milestones'
06/22/22 Loop Capital
Samsung initiated with a Buy at Loop Capital
XPEV XPeng
$10.10 /

-1.8 (-15.13%)

WWE WWE
$84.15 /

+12.1 (+16.79%)

ULTA Ulta Beauty
$486.31 /

-2.83 (-0.58%)

TSLA Tesla
$113.01 /

+2.635 (+2.39%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$12.22 /

-0.34 (-2.71%)

RTX Raytheon Technologies
$102.45 /

+1.58 (+1.57%)

PFE Pfizer
$50.91 /

+1.2548 (+2.53%)

MCD McDonald's
$269.57 /

+7.4 (+2.82%)

LUV Southwest
$35.09 /

+1.56 (+4.65%)

LULU Lululemon
$329.32 /

+3.385 (+1.04%)

LAZR Luminar
$3.95 /

-0.385 (-8.89%)

JPM JPMorgan
$137.93 /

+2.57 (+1.90%)

JNJ Johnson & Johnson
$180.25 /

+1.46 (+0.82%)

HTGM HTG Molecular
$3.32 /

-0.35 (-9.54%)

GBX Greenbrier
$28.67 /

-6.23 (-17.85%)

FATE Fate Therapeutics
$4.24 /

-6.725 (-61.33%)

BOOT Boot Barn
$61.98 /

-0.945 (-1.50%)

BIIB Biogen
$279.39 /

+7.84 (+2.89%)

BAX Baxter
$48.46 /

-4.1 (-7.80%)

BAC Bank of America
$34.42 /

+0.355 (+1.04%)

AUPH Aurinia Pharmaceuticals
$7.55 /

+0.675 (+9.82%)

ATAI Atai Life Sciences
$1.80 /

-0.845 (-32.01%)

AMRN Amarin
$1.45 /

+0.195 (+15.60%)

ALGS Aligos Therapeutics
$1.29 /

+0.2974 (+29.96%)

AEHR Aehr Test Systems
$22.80 /

+5.555 (+32.21%)

WWE WWE
$84.15 /

+12.1 (+16.79%)

TSLA Tesla
$113.01 /

+2.635 (+2.39%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$12.22 /

-0.34 (-2.71%)

RTX Raytheon Technologies
$102.45 /

+1.58 (+1.57%)

PFE Pfizer
$50.91 /

+1.2548 (+2.53%)

MCD McDonald's
$269.57 /

+7.4 (+2.82%)

LUV Southwest
$35.09 /

+1.56 (+4.65%)

LULU Lululemon
$329.32 /

+3.385 (+1.04%)

LAZR Luminar
$3.95 /

-0.385 (-8.89%)

JPM JPMorgan
$137.93 /

+2.57 (+1.90%)

JNJ Johnson & Johnson
$180.25 /

+1.46 (+0.82%)

BZLFY Bunzl
$35.00 /

+1.01 (+2.97%)

BOOT Boot Barn
$61.98 /

-0.945 (-1.50%)

BIIB Biogen
$279.39 /

+7.84 (+2.89%)

BAX Baxter
$48.46 /

-4.1 (-7.80%)

BAC Bank of America
$34.42 /

+0.355 (+1.04%)

AUPH Aurinia Pharmaceuticals
$7.55 /

+0.675 (+9.82%)

ATAI Atai Life Sciences
$1.80 /

-0.845 (-32.01%)

AMRN Amarin
$1.45 /

+0.195 (+15.60%)

XPEV XPeng
$10.10 /

-1.8 (-15.13%)

WWE WWE
$84.15 /

+12.1 (+16.79%)

ULTA Ulta Beauty
$486.31 /

-2.83 (-0.58%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$12.22 /

-0.34 (-2.71%)

RTX Raytheon Technologies
$102.45 /

+1.58 (+1.57%)

PFE Pfizer
$50.91 /

+1.2548 (+2.53%)

MCD McDonald's
$269.57 /

+7.4 (+2.82%)

LUV Southwest
$35.09 /

+1.56 (+4.65%)

LULU Lululemon
$329.32 /

+3.385 (+1.04%)

LAZR Luminar
$3.95 /

-0.385 (-8.89%)

JPM JPMorgan
$137.93 /

+2.57 (+1.90%)

JNJ Johnson & Johnson
$180.25 /

+1.46 (+0.82%)

GBX Greenbrier
$28.67 /

-6.23 (-17.85%)

ESALY Eisai
$64.20 /

+2.53 (+4.10%)

BOOT Boot Barn
$61.98 /

-0.945 (-1.50%)

BIIB Biogen
$279.39 /

+7.84 (+2.89%)

BAX Baxter
$48.46 /

-4.1 (-7.80%)

BAC Bank of America
$34.42 /

+0.355 (+1.04%)

AUPH Aurinia Pharmaceuticals
$7.55 /

+0.675 (+9.82%)

ATAI Atai Life Sciences
$1.80 /

-0.845 (-32.01%)

AMRN Amarin
$1.45 /

+0.195 (+15.60%)

AEHR Aehr Test Systems
$22.80 /

+5.555 (+32.21%)

XPEV XPeng
$10.10 /

-1.8 (-15.13%)

ULTA Ulta Beauty
$486.31 /

-2.83 (-0.58%)

TSLA Tesla
$113.01 /

+2.635 (+2.39%)

SI Silvergate Capital
$12.22 /

-0.34 (-2.71%)

RTX Raytheon Technologies
$102.45 /

+1.58 (+1.57%)

PFE Pfizer
$50.91 /

+1.2548 (+2.53%)

MCD McDonald's
$269.57 /

+7.4 (+2.82%)

LUV Southwest
$35.09 /

+1.56 (+4.65%)

LULU Lululemon
$329.32 /

+3.385 (+1.04%)

LAZR Luminar
$3.95 /

-0.385 (-8.89%)

JPM JPMorgan
$137.93 /

+2.57 (+1.90%)

JNJ Johnson & Johnson
$180.25 /

+1.46 (+0.82%)

BIIB Biogen
$279.39 /

+7.84 (+2.89%)

BAX Baxter
$48.46 /

-4.1 (-7.80%)

BAC Bank of America
$34.42 /

+0.355 (+1.04%)

AUPH Aurinia Pharmaceuticals
$7.55 /

+0.675 (+9.82%)

AEHR Aehr Test Systems
$22.80 /

+5.555 (+32.21%)

On The Fly
What You Missed On Wall Street This Morning » 12:19
01/06/23
01/06
12:19
01/06/23
12:19
LUV

Southwest

$34.42 /

+0.89 (+2.65%)

, BAX

Baxter

$49.99 /

-2.57 (-4.89%)

, WWE

WWE

$88.13 /

+16.08 (+22.32%)

, TSLA

Tesla

$111.66 /

+1.29 (+1.17%)

, FATE

Fate Therapeutics

$4.21 /

-6.755 (-61.61%)

, JNJ

Johnson & Johnson

$179.88 /

+1.09 (+0.61%)

, LAZR

Luminar

$4.06 /

-0.27 (-6.24%)

, WBD

Warner Bros. Discovery

$11.18 /

+0.325 (+2.99%)

, BZLFY

Bunzl

$33.99 /

-0.35 (-1.02%)

, RTX

Raytheon Technologies

$103.64 /

+2.77 (+2.75%)

, BOOT

Boot Barn

$62.18 /

-0.74 (-1.18%)

, HTGM

HTG Molecular

$3.37 /

-0.3 (-8.17%)

, GBX

Greenbrier

$29.97 /

-4.93 (-14.13%)

, AUPH

Aurinia Pharmaceuticals

$7.60 /

+0.725 (+10.55%)

, SSNLF

Samsung

$40.60 /

+ (+0.00%)

, JPM

JPMorgan

$137.36 /

+2 (+1.48%)

, BAC

Bank of America

$34.44 /

+0.37 (+1.09%)

, LULU

Lululemon

$330.17 /

+4.235 (+1.30%)

, ALGS

Aligos Therapeutics

$1.19 /

+0.1974 (+19.89%)

, MDGL

Madrigal Pharmaceuticals

$275.35 /

+3.77 (+1.39%)

, ULTA

Ulta Beauty

$484.25 /

-4.89 (-1.00%)

, SI

Silvergate Capital

$10.96 /

-1.6 (-12.74%)

, PFE

Pfizer

$50.76 /

+1.105 (+2.23%)

Get caught up quickly on…

ShowHide Related Items >><<
WWE WWE
$88.13 /

+16.08 (+22.32%)

WBD Warner Bros. Discovery
$11.18 /

+0.325 (+2.99%)

ULTA Ulta Beauty
$484.25 /

-4.89 (-1.00%)

TSLA Tesla
$111.66 /

+1.29 (+1.17%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$10.96 /

-1.6 (-12.74%)

RTX Raytheon Technologies
$103.64 /

+2.77 (+2.75%)

PFE Pfizer
$50.76 /

+1.105 (+2.23%)

MDGL Madrigal Pharmaceuticals
$275.35 /

+3.77 (+1.39%)

LUV Southwest
$34.42 /

+0.89 (+2.65%)

LULU Lululemon
$330.17 /

+4.235 (+1.30%)

LAZR Luminar
$4.06 /

-0.27 (-6.24%)

JPM JPMorgan
$137.36 /

+2 (+1.48%)

JNJ Johnson & Johnson
$179.88 /

+1.09 (+0.61%)

HTGM HTG Molecular
$3.37 /

-0.3 (-8.17%)

GBX Greenbrier
$29.97 /

-4.93 (-14.13%)

FATE Fate Therapeutics
$4.21 /

-6.755 (-61.61%)

BOOT Boot Barn
$62.18 /

-0.74 (-1.18%)

BAX Baxter
$49.99 /

-2.57 (-4.89%)

BAC Bank of America
$34.44 /

+0.37 (+1.09%)

AUPH Aurinia Pharmaceuticals
$7.60 /

+0.725 (+10.55%)

ALGS Aligos Therapeutics
$1.19 /

+0.1974 (+19.89%)

LUV Southwest
$34.42 /

+0.89 (+2.65%)

12/16/22 Goldman Sachs
Southwest resumed with a Neutral at Goldman Sachs
12/15/22 Cowen
Copa Holdings upgraded to Outperform at Cowen amid airlines rating shake-up
12/08/22 Susquehanna
Southwest guidance suggests risk around order book, says Susquehanna
12/08/22 Deutsche Bank
Southwest price target raised to $62 from $60 at Deutsche Bank
BAX Baxter
$49.99 /

-2.57 (-4.89%)

01/06/23 Morgan Stanley
Baxter downgraded to Equal Weight from Overweight at Morgan Stanley
01/05/23 Raymond James
Baxter downgraded to Market Perform from Outperform at Raymond James
01/04/23 Barclays
Baxter price target lowered to $63 from $64 at Barclays
01/03/23 BofA
BofA downgrades Baxter to Neutral, prefers Becton Dickinson
WWE WWE
$88.13 /

+16.08 (+22.32%)

01/06/23 Loop Capital
WWE price target raised to $105 from $90 at Loop Capital
01/06/23 MKM Partners
MKM Partners sees WWE as 'very attractive asset' if it goes for sale
11/29/22 Morgan Stanley
WWE price target raised to $80 from $75 at Morgan Stanley
10/19/22 MKM Partners
WWE price target raised to $90 from $84 at MKM Partners
TSLA Tesla
$111.66 /

+1.29 (+1.17%)

01/06/23 BofA
XPeng downgraded to Neutral at BofA after Tesla price cuts
01/06/23 GLJ Research
Tesla price cuts in China 'much worse than you think,' says GLJ Research
01/05/23 Edward Jones
Edward Jones upgrades Tesla on long-term growth opportunities
01/05/23 Edward Jones
Tesla upgraded to Buy from Hold at Edward Jones
FATE Fate Therapeutics
$4.21 /

-6.755 (-61.61%)

01/06/23 Truist
Truist cuts Fate Therapeutics to Hold after discontinuing Janssen collaboration
01/06/23 BofA
Fate Therapeutics double downgraded to Underperform at BofA
01/06/23 BofA
Fate Therapeutics downgraded to Underperform from Buy at BofA
01/06/23 Wedbush
Fate Therapeutics downgraded to Neutral from Outperform at Wedbush
JNJ Johnson & Johnson
$179.88 /

+1.09 (+0.61%)

01/06/23 BMO Capital
Fate Therapeutics downgraded to Market Perform from Outperform at BMO Capital
01/03/23 Wells Fargo
Wells Fargo upgrades Immunovant to Overweight, raises price target to $27
LAZR Luminar
$4.06 /

-0.27 (-6.24%)

12/20/22 JPMorgan
Luminar price target lowered to $16 from $30 at JPMorgan
12/07/22 Citi
Luminar price target lowered to $20 from $21 at Citi
11/16/22 Berenberg
Berenberg says top LiDAR idea Innoviz Technologies undervalued
11/01/22 WestPark Capital
Luminar initiated with a Buy at WestPark Capital
WBD Warner Bros. Discovery
$11.18 /

+0.325 (+2.99%)

01/04/23 Macquarie
Warner Bros. Discovery price target lowered to $16 from $18 at Macquarie
12/07/22 BofA
Warner Bros. Discovery the 'best value in media,' says BofA
11/14/22 Spin-Off Research
Warner Bros. Discovery downgraded to Hold from Buy at Spin-Off Research
11/10/22 Citi
Warner Bros. Discovery price target lowered to $18 from $21 at Citi
BZLFY Bunzl
$33.99 /

-0.35 (-1.02%)

12/16/22 Barclays
Bunzl downgraded to Underweight from Equal Weight at Barclays
11/14/22 Credit Suisse
Bunzl assumed with a Neutral at Credit Suisse
08/31/22 JPMorgan
Bunzl price target raised to 3,250 GBp from 3,200 GBp at JPMorgan
08/19/22 Jefferies
Bunzl downgraded to Hold from Buy at Jefferies
RTX Raytheon Technologies
$103.64 /

+2.77 (+2.75%)

12/08/22 Citi
Raytheon Technologies initiated with a Neutral at Citi
11/28/22 Cowen
Raytheon Technologies a Best Idea for 2023, says Cowen
10/26/22 Morgan Stanley
Raytheon Technologies price target lowered to $119 from $124 at Morgan Stanley
10/26/22 Baird
Raytheon Technologies price target lowered to $106 from $117 at Baird
BOOT Boot Barn
$62.18 /

-0.74 (-1.18%)

01/06/23 BofA
Boot Barn initiated with a Buy, $85 price target at BofA
01/06/23 BofA
Boot Barn initiated with a Buy at BofA
01/04/23 Citi
Citi ups Boot Barn target, expects positive preannouncement
01/03/23 JPMorgan
Boot Barn price target raised to $94 from $92 at JPMorgan
HTGM HTG Molecular
$3.37 /

-0.3 (-8.17%)

12/29/22 H.C. Wainwright
H.C. Wainwright institutes $15 price target on HTG Molecular shares
07/22/22 Cantor Fitzgerald
HTG Molecular price target lowered to $3.50 from $15 at Cantor Fitzgerald
05/16/22 H.C. Wainwright
HTG Molecular price target lowered to $3 from $4 at H.C. Wainwright
03/30/22 H.C. Wainwright
HTG Molecular price target lowered to $4 from $9 at H.C. Wainwright
GBX Greenbrier
$29.97 /

-4.93 (-14.13%)

11/07/22 Susquehanna
Greenbrier downgraded to Neutral from Positive at Susquehanna
07/13/22 Cowen
Greenbrier price target lowered to $47 from $54
07/12/22 Susquehanna
Greenbrier price target lowered to $38 from $58 at Susquehanna
07/11/22 BofA
Greenbrier downgraded to Neutral at BofA after Q3 earnings miss
AUPH Aurinia Pharmaceuticals
$7.60 /

+0.725 (+10.55%)

01/03/23 RBC Capital
Aurinia price target raised to $11 from $10 at RBC Capital
11/07/22 H.C. Wainwright
Aurinia Pharmaceuticals price target lowered to $14 from $26 at H.C. Wainwright
11/04/22 Oppenheimer
Oppenheimer downgrades Aurinia on commercial challenges
11/04/22 Oppenheimer
Aurinia Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer
SSNLF Samsung
$40.60 /

+ (+0.00%)

11/25/22 William Blair
Report about Galaxy S23 'significant positive' for Iridium, says William Blair
08/22/22 Loop Capital
Enovix price target raised to $100 from $50 at Loop Capital
08/11/22 Loop Capital
Loop Capital has 'stronger conviction' in Enovix after 'customer milestones'
06/22/22 Loop Capital
Samsung initiated with a Buy at Loop Capital
JPM JPMorgan
$137.36 /

+2 (+1.48%)

01/06/23 Deutsche Bank
JPMorgan downgraded to Hold with $145 target at Deutsche Bank
01/06/23 Deutsche Bank
JPMorgan downgraded to Hold from Buy at Deutsche Bank
01/03/23 Barclays
JPMorgan price target raised to $189 from $162 at Barclays
12/28/22 Oppenheimer
JPMorgan price target lowered to $169 from $174 at Oppenheimer
BAC Bank of America
$34.44 /

+0.37 (+1.09%)

01/06/23 Deutsche Bank
Bank of America downgraded to Hold with $36 target at Deutsche Bank
01/06/23 Deutsche Bank
Bank of America downgraded to Hold from Buy at Deutsche Bank
01/03/23 Barclays
Bank of America price target lowered to $48 from $51 at Barclays
12/28/22 Oppenheimer
Bank of America price target lowered to $51 from $52 at Oppenheimer
LULU Lululemon
$330.17 /

+4.235 (+1.30%)

01/06/23 Wells Fargo
Lululemon upgraded to Overweight from Equal Weight at Wells Fargo
01/06/23 Wells Fargo
Lululemon upgraded to Overweight from Equal Weight at Wells Fargo
01/05/23 Piper Sandler
Lululemon price target lowered to $385 from $390 at Piper Sandler
12/12/22 Argus
Lululemon selloff presents buying opportunity, says Argus
ALGS Aligos Therapeutics
$1.19 /

+0.1974 (+19.89%)

01/06/23 Piper Sandler
Aligos upgraded to Overweight at Piper after peer's 'highly encouraging' data
01/06/23 Piper Sandler
Aligos Therapeutics upgraded to Overweight from Neutral at Piper Sandler
01/06/23 Jefferies
Jefferies upgrades Aligos to Buy on derisking of NASH pill
01/06/23 Jefferies
Aligos Therapeutics upgraded to Buy from Hold at Jefferies
MDGL Madrigal Pharmaceuticals
$275.35 /

+3.77 (+1.39%)

01/06/23 Canaccord
Madrigal Pharmaceuticals price target raised to $296 from $270 at Canaccord
01/05/23 JMP Securities
Madrigal Pharmaceuticals price target raised to $390 from $312 at JMP Securities
ULTA Ulta Beauty
$484.25 /

-4.89 (-1.00%)

01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/05/23 Argus
Ulta Beauty price target raised to $530 from $455 at Argus
12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
SI Silvergate Capital
$10.96 /

-1.6 (-12.74%)

01/06/23 Craig-Hallum
Silvergate Capital downgraded to Hold from Buy at Craig-Hallum
01/06/23 BofA
BofA downgrades Silvergate to Underperform with 'more questions than answers'
01/06/23 BofA
Silvergate Capital downgraded to Underperform from Neutral at BofA
01/06/23 Canaccord
Silvergate Capital price target lowered to $25 from $150 at Canaccord
PFE Pfizer
$50.76 /

+1.105 (+2.23%)

01/05/23 Morgan Stanley
Morgan Stanley sees Moderna's phase 3 RSV vaccine data as catalyst-driven idea
01/04/23 BofA
BioMarin price target raised to $200, added to 'US 1 List' at BofA
01/04/23 BofA
Pfizer downgraded to Neutral at BofA on COVID-19 uncertainty
01/04/23 BofA
Pfizer downgraded to Neutral from Buy at BofA
WWE WWE
$88.13 /

+16.08 (+22.32%)

WBD Warner Bros. Discovery
$11.18 /

+0.325 (+2.99%)

ULTA Ulta Beauty
$484.25 /

-4.89 (-1.00%)

TSLA Tesla
$111.66 /

+1.29 (+1.17%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$10.96 /

-1.6 (-12.74%)

RTX Raytheon Technologies
$103.64 /

+2.77 (+2.75%)

PFE Pfizer
$50.76 /

+1.105 (+2.23%)

MDGL Madrigal Pharmaceuticals
$275.35 /

+3.77 (+1.39%)

LUV Southwest
$34.42 /

+0.89 (+2.65%)

LULU Lululemon
$330.17 /

+4.235 (+1.30%)

LAZR Luminar
$4.06 /

-0.27 (-6.24%)

JPM JPMorgan
$137.36 /

+2 (+1.48%)

JNJ Johnson & Johnson
$179.88 /

+1.09 (+0.61%)

HTGM HTG Molecular
$3.37 /

-0.3 (-8.17%)

GBX Greenbrier
$29.97 /

-4.93 (-14.13%)

FATE Fate Therapeutics
$4.21 /

-6.755 (-61.61%)

BOOT Boot Barn
$62.18 /

-0.74 (-1.18%)

BAX Baxter
$49.99 /

-2.57 (-4.89%)

BAC Bank of America
$34.44 /

+0.37 (+1.09%)

AUPH Aurinia Pharmaceuticals
$7.60 /

+0.725 (+10.55%)

ALGS Aligos Therapeutics
$1.19 /

+0.1974 (+19.89%)

WWE WWE
$88.13 /

+16.08 (+22.32%)

WBD Warner Bros. Discovery
$11.18 /

+0.325 (+2.99%)

TSLA Tesla
$111.66 /

+1.29 (+1.17%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$10.96 /

-1.6 (-12.74%)

RTX Raytheon Technologies
$103.64 /

+2.77 (+2.75%)

PFE Pfizer
$50.76 /

+1.105 (+2.23%)

LUV Southwest
$34.42 /

+0.89 (+2.65%)

LULU Lululemon
$330.17 /

+4.235 (+1.30%)

LAZR Luminar
$4.06 /

-0.27 (-6.24%)

JPM JPMorgan
$137.36 /

+2 (+1.48%)

JNJ Johnson & Johnson
$179.88 /

+1.09 (+0.61%)

BZLFY Bunzl
$33.99 /

-0.35 (-1.02%)

BOOT Boot Barn
$62.18 /

-0.74 (-1.18%)

BAX Baxter
$49.99 /

-2.57 (-4.89%)

BAC Bank of America
$34.44 /

+0.37 (+1.09%)

AUPH Aurinia Pharmaceuticals
$7.60 /

+0.725 (+10.55%)

WWE WWE
$88.13 /

+16.08 (+22.32%)

WBD Warner Bros. Discovery
$11.18 /

+0.325 (+2.99%)

ULTA Ulta Beauty
$484.25 /

-4.89 (-1.00%)

TSLA Tesla
$111.66 /

+1.29 (+1.17%)

SSNLF Samsung
$40.60 /

+ (+0.00%)

SI Silvergate Capital
$10.96 /

-1.6 (-12.74%)

RTX Raytheon Technologies
$103.64 /

+2.77 (+2.75%)

PFE Pfizer
$50.76 /

+1.105 (+2.23%)

MDGL Madrigal Pharmaceuticals
$275.35 /

+3.77 (+1.39%)

LUV Southwest
$34.42 /

+0.89 (+2.65%)

LULU Lululemon
$330.17 /

+4.235 (+1.30%)

LAZR Luminar
$4.06 /

-0.27 (-6.24%)

JPM JPMorgan
$137.36 /

+2 (+1.48%)

JNJ Johnson & Johnson
$179.88 /

+1.09 (+0.61%)

GBX Greenbrier
$29.97 /

-4.93 (-14.13%)

FATE Fate Therapeutics
$4.21 /

-6.755 (-61.61%)

BOOT Boot Barn
$62.18 /

-0.74 (-1.18%)

BAX Baxter
$49.99 /

-2.57 (-4.89%)

BAC Bank of America
$34.44 /

+0.37 (+1.09%)

AUPH Aurinia Pharmaceuticals
$7.60 /

+0.725 (+10.55%)

WBD Warner Bros. Discovery
$11.18 /

+0.325 (+2.99%)

ULTA Ulta Beauty
$484.25 /

-4.89 (-1.00%)

TSLA Tesla
$111.66 /

+1.29 (+1.17%)

SI Silvergate Capital
$10.96 /

-1.6 (-12.74%)

RTX Raytheon Technologies
$103.64 /

+2.77 (+2.75%)

PFE Pfizer
$50.76 /

+1.105 (+2.23%)

MDGL Madrigal Pharmaceuticals
$275.35 /

+3.77 (+1.39%)

LUV Southwest
$34.42 /

+0.89 (+2.65%)

LULU Lululemon
$330.17 /

+4.235 (+1.30%)

LAZR Luminar
$4.06 /

-0.27 (-6.24%)

JPM JPMorgan
$137.36 /

+2 (+1.48%)

JNJ Johnson & Johnson
$179.88 /

+1.09 (+0.61%)

BAX Baxter
$49.99 /

-2.57 (-4.89%)

BAC Bank of America
$34.44 /

+0.37 (+1.09%)

AUPH Aurinia Pharmaceuticals
$7.60 /

+0.725 (+10.55%)

Downgrade
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo » 06:26
01/06/23
01/06
06:26
01/06/23
06:26
ULTA

Ulta Beauty

$488.98 /

+6.13 (+1.27%)

Wells Fargo analyst Ike…

Wells Fargo analyst Ike Boruchow downgraded Ulta Beauty to Underweight from Equal Weight with a price target of $400, down from $450. The space is coming off its worst year since the global financial crisis as demand broke down, inventory ballooned, and costs spiked, and Boruchow sees a very challenging catalyst path heading into 2023, the analyst tells investors in a research note. Additionally, holiday results were likely "OK" at best, and with a difficult Q1 setup looming, Street numbers that will likely be coming down on weaker initial guidance, the analyst contends.

ShowHide Related Items >><<
ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

01/06/23 Wells Fargo
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo
01/05/23 Argus
Ulta Beauty price target raised to $530 from $455 at Argus
12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
12/05/22 Barclays
Ulta Beauty price target raised to $548 from $511 at Barclays
ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

Downgrade
Ulta Beauty downgraded to Underweight from Equal Weight at Wells Fargo » 05:30
01/06/23
01/06
05:30
01/06/23
05:30
ULTA

Ulta Beauty

$488.98 /

+6.13 (+1.27%)

Wells Fargo analyst Ike…

Wells Fargo analyst Ike Boruchow downgraded Ulta Beauty to Underweight from Equal Weight with a price target of $400, down from $450.

ShowHide Related Items >><<
ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

01/05/23 Argus
Ulta Beauty price target raised to $530 from $455 at Argus
12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
12/05/22 Barclays
Ulta Beauty price target raised to $548 from $511 at Barclays
12/02/22 DA Davidson
Ulta Beauty price target raised to $545 from $490 at DA Davidson
ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

ULTA Ulta Beauty
$488.98 /

+6.13 (+1.27%)

Recommendations
Ulta Beauty price target raised to $530 from $455 at Argus » 07:45
01/05/23
01/05
07:45
01/05/23
07:45
ULTA

Ulta Beauty

$483.56 /

+11.7 (+2.48%)

Argus analyst Kristina…

Argus analyst Kristina Ruggeri raised the firm's price target on Ulta Beauty to $530 from $455 and keeps a Buy rating on the shares. The analyst is positive on the company's business partnerships, loyalty programs, strong customer engagement, and new focus on wellness. Ruggeri also cites Ulta's most recent operating margin of 15.5% coming in at a record high. The analyst is raising her FY23 EPS view on the stock to $22.75 from $21.00 and her FY24 view to $23.82 from $22.55.

ShowHide Related Items >><<
ULTA Ulta Beauty
$483.56 /

+11.7 (+2.48%)

ULTA Ulta Beauty
$483.56 /

+11.7 (+2.48%)

12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
12/05/22 Barclays
Ulta Beauty price target raised to $548 from $511 at Barclays
12/02/22 DA Davidson
Ulta Beauty price target raised to $545 from $490 at DA Davidson
12/02/22 Deutsche Bank
Ulta Beauty price target raised to $607 from $589 at Deutsche Bank
ULTA Ulta Beauty
$483.56 /

+11.7 (+2.48%)

ULTA Ulta Beauty
$483.56 /

+11.7 (+2.48%)

ULTA Ulta Beauty
$483.56 /

+11.7 (+2.48%)

Over a month ago
On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:12
12/12/22
12/12
10:12
12/12/22
10:12
TPR

Tapestry

$36.60 /

+0.2 (+0.55%)

, GPS

Gap

$13.96 /

+0.05 (+0.36%)

, BBY

Best Buy

$80.90 /

-0.04 (-0.05%)

, UA

Under Armour

$8.60 /

+0.245 (+2.93%)

, UAA

Under Armour

$9.85 /

+0.32 (+3.36%)

, BDX

Becton Dickinson

$249.85 /

+2.38 (+0.96%)

, LRCX

Lam Research

$450.50 /

+0.275 (+0.06%)

, QCOM

Qualcomm

$117.64 /

-1.4 (-1.18%)

, MU

Micron

$53.87 /

-1 (-1.82%)

, DKNG

DraftKings

$13.93 /

-0.035 (-0.25%)

, ULTA

Ulta Beauty

$467.55 /

-4.16 (-0.88%)

, ILMN

Illumina

$204.06 /

-1.69 (-0.82%)

, LH

Labcorp

$226.38 /

-7.65 (-3.27%)

, COIN

Coinbase

$40.27 /

+0.01 (+0.02%)

, AMOT

Allied Motion

$34.67 /

-0.04 (-0.12%)

, PLMR

Palomar

$51.08 /

-0.62 (-1.20%)

, KNSL

Kinsale Capital Group

$283.99 /

-3.51 (-1.22%)

, RGLD

Royal Gold

$108.65 /

-1.97 (-1.78%)

Institutional investors…

ShowHide Related Items >><<
ULTA Ulta Beauty
$467.55 /

-4.16 (-0.88%)

UA Under Armour
$8.60 /

+0.245 (+2.93%)

TPR Tapestry
$36.60 /

+0.2 (+0.55%)

RGLD Royal Gold
$108.65 /

-1.97 (-1.78%)

QCOM Qualcomm
$117.64 /

-1.4 (-1.18%)

PLMR Palomar
$51.08 /

-0.62 (-1.20%)

MU Micron
$53.87 /

-1 (-1.82%)

LRCX Lam Research
$450.50 /

+0.275 (+0.06%)

LH Labcorp
$226.38 /

-7.65 (-3.27%)

ILMN Illumina
$204.06 /

-1.69 (-0.82%)

GPS Gap
$13.96 /

+0.05 (+0.36%)

DKNG DraftKings
$13.93 /

-0.035 (-0.25%)

COIN Coinbase
$40.27 /

+0.01 (+0.02%)

BDX Becton Dickinson
$249.85 /

+2.38 (+0.96%)

BBY Best Buy
$80.90 /

-0.04 (-0.05%)

AMOT Allied Motion
$34.67 /

-0.04 (-0.12%)

TPR Tapestry
$36.60 /

+0.2 (+0.55%)

12/12/22 Goldman Sachs
Tapestry upgraded to Buy from Neutral at Goldman Sachs
11/29/22 JPMorgan
Tapestry price target raised to $47 from $46 at JPMorgan
11/14/22 Citi
Tapestry price target lowered to $40 from $42 at Citi
11/11/22 Morgan Stanley
Tapestry price target lowered to $35 from $39 at Morgan Stanley
GPS Gap
$13.96 /

+0.05 (+0.36%)

12/12/22 Goldman Sachs
Gap upgraded to Buy from Neutral at Goldman Sachs
11/21/22 Deutsche Bank
Gap price target raised to $11 from $8 at Deutsche Bank
11/21/22 Barclays
Gap price target raised to $14 from $9 at Barclays
11/18/22 Jefferies
Gap price target raised to $13 from $11 at Jefferies
BBY Best Buy
$80.90 /

-0.04 (-0.05%)

12/12/22 Goldman Sachs
Best Buy upgraded to Neutral from Sell at Goldman Sachs
11/28/22 Goldman Sachs
Goldman finds small crowds, more promotions over Black Friday weekend
11/28/22 Wedbush
Black Friday winners Include Best Buy, losers include Pets, says Wedbush
11/23/22 BofA
Best Buy price target raised to $80 from $75 at BofA
UA Under Armour
$8.60 /

+0.245 (+2.93%)

12/12/22 Stifel
Under Armour upgraded to Buy from Hold at Stifel
11/07/22 JPMorgan
Under Armour price target raised to $11 from $10 at JPMorgan
11/01/22 BofA
Under Armour reinstated with a Neutral at BofA
10/31/22 JPMorgan
Under Armour price target lowered to $10 from $12 at JPMorgan
UAA Under Armour
$9.85 /

+0.32 (+3.36%)

BDX Becton Dickinson
$249.85 /

+2.38 (+0.96%)

12/12/22 Citi
Becton Dickinson upgraded to Neutral from Sell at Citi
12/12/22 Citi
Becton Dickinson upgraded to Neutral from Sell at Citi
11/16/22 Evercore ISI
Evercore ISI removes seven Healthcare Services and Tech stocks from 'TAP' list
11/14/22 Citi
Becton Dickinson price target lowered to $220 from $227 at Citi
LRCX Lam Research
$450.50 /

+0.275 (+0.06%)

12/12/22 Deutsche Bank
Lam Research upgraded to Buy from Hold at Deutsche Bank
10/20/22 Jefferies
Lam Research price target lowered to $525 from $535 at Jefferies
10/20/22 Evercore ISI
Lam Research price target lowered to $450 from $500 at Evercore ISI
10/20/22 Wells Fargo
Lam Research price target lowered to $350 from $410 at Wells Fargo
QCOM Qualcomm
$117.64 /

-1.4 (-1.18%)

12/12/22 Wells Fargo
Wells Fargo downgrades Qualcomm to Underweight with $105 price target
12/12/22 Wells Fargo
Qualcomm downgraded to Underweight from Equal Weight at Wells Fargo
11/15/22 Credit Suisse
Qualcomm initiated with an Outperform at Credit Suisse
11/03/22 KeyBanc
Qualcomm price target lowered to $150 from $170 at KeyBanc
MU Micron
$53.87 /

-1 (-1.82%)

12/12/22 Deutsche Bank
Micron downgraded to Hold from Buy at Deutsche Bank
12/07/22 Wells Fargo
Micron price target lowered to $70 from $75 at Wells Fargo
12/05/22 Lynx
Micron price target raised to $60 from $56 at Lynx
11/30/22 Stifel
Micron management's tone 'incrementally downbeat,' says Stifel
DKNG DraftKings
$13.93 /

-0.035 (-0.25%)

12/12/22 Roth MKM
Roth Capital downgrades DraftKings to Neutral, keeps $15 price target
12/12/22 Roth MKM
DraftKings downgraded to Neutral from Buy at Roth Capital
11/29/22 JMP Securities
DraftKings deal with Churchill an attractive opportunity, says JMP Securities
11/29/22 Piper Sandler
Piper sees 'several' positives in DraftKings horse racing pact
ULTA Ulta Beauty
$467.55 /

-4.16 (-0.88%)

12/12/22 Goldman Sachs
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs
12/05/22 Barclays
Ulta Beauty price target raised to $548 from $511 at Barclays
12/02/22 DA Davidson
Ulta Beauty price target raised to $545 from $490 at DA Davidson
12/02/22 Deutsche Bank
Ulta Beauty price target raised to $607 from $589 at Deutsche Bank
ILMN Illumina
$204.06 /

-1.69 (-0.82%)

12/12/22 Citi
Illumina downgraded to Sell from Neutral at Citi
12/12/22 Citi
Illumina downgraded to Sell from Neutral at Citi
12/06/22 RBC Capital
Illumina initiated with an Outperform at RBC Capital
12/06/22 Canaccord
Illumina divestment for GRAIL buy worth the wait, says Canaccord
LH Labcorp
$226.38 /

-7.65 (-3.27%)

12/12/22 Citi
Labcorp downgraded to Neutral from Buy at Citi
12/12/22 Citi
Labcorp downgraded to Neutral from Buy at Citi
11/30/22 Wells Fargo
Bust of smuggling ring likely to beheadwind for LabCorp, says Wells Fargo
11/17/22 Citi
Quest Diagnostics downgraded to Sell from Neutral at Citi
COIN Coinbase
$40.27 /

+0.01 (+0.02%)

12/12/22 KeyBanc
Coinbase initiated with a Sector Weight at KeyBanc
12/12/22 Mizuho
Fiserv price target lowered to $135 from $145 at Mizuho
12/09/22 Mizuho
Coinbase downgraded to Underperform from Neutral at Mizuho
12/05/22 Atlantic Equities
Coinbase price target lowered to $46 from $67 at Atlantic Equities
AMOT Allied Motion
$34.67 /

-0.04 (-0.12%)

12/12/22 Northland
Allied Motion initiated with an Outperform at Northland
PLMR Palomar
$51.08 /

-0.62 (-1.20%)

12/12/22 Jefferies
Palomar initiated with a Hold at Jefferies
11/07/22 Barclays
Palomar price target lowered to $93 from $102 at Barclays
10/18/22 JMP Securities
Palomar downgraded to Market Perform from Outperform at JMP Securities
10/14/22 Barclays
Palomar price target raised to $102 from $80 at Barclays
KNSL Kinsale Capital Group
$283.99 /

-3.51 (-1.22%)

12/12/22 Jefferies
Kinsale Capital Group initiated with a Hold at Jefferies
10/31/22 Truist
Kinsale Capital Group price target raised to $335 from $285 at Truist
10/31/22 RBC Capital
Kinsale Capital Group price target raised to $350 from $275 at RBC Capital
08/15/22 Compass Point
Kinsale Capital Group downgraded to Neutral from Buy at Compass Point
RGLD Royal Gold
$108.65 /

-1.97 (-1.78%)

12/12/22 Credit Suisse
Royal Gold initiated with a Neutral at Credit Suisse
10/17/22 Barclays
Royal Gold price target lowered to $108 from $110 at Barclays
08/05/22 Raymond James
Royal Gold price target lowered to C$142 from C$144 at Raymond James
07/21/22 National Bank
Royal Gold price target lowered to $150 from $165 at National Bank
ULTA Ulta Beauty
$467.55 /

-4.16 (-0.88%)

UA Under Armour
$8.60 /

+0.245 (+2.93%)

TPR Tapestry
$36.60 /

+0.2 (+0.55%)

RGLD Royal Gold
$108.65 /

-1.97 (-1.78%)

QCOM Qualcomm
$117.64 /

-1.4 (-1.18%)

PLMR Palomar
$51.08 /

-0.62 (-1.20%)

MU Micron
$53.87 /

-1 (-1.82%)

LRCX Lam Research
$450.50 /

+0.275 (+0.06%)

LH Labcorp
$226.38 /

-7.65 (-3.27%)

KNSL Kinsale Capital Group
$283.99 /

-3.51 (-1.22%)

ILMN Illumina
$204.06 /

-1.69 (-0.82%)

GPS Gap
$13.96 /

+0.05 (+0.36%)

DKNG DraftKings
$13.93 /

-0.035 (-0.25%)

COIN Coinbase
$40.27 /

+0.01 (+0.02%)

BDX Becton Dickinson
$249.85 /

+2.38 (+0.96%)

BBY Best Buy
$80.90 /

-0.04 (-0.05%)

  • 11
    Nov
UA Under Armour
$8.60 /

+0.245 (+2.93%)

TPR Tapestry
$36.60 /

+0.2 (+0.55%)

QCOM Qualcomm
$117.64 /

-1.4 (-1.18%)

MU Micron
$53.87 /

-1 (-1.82%)

LRCX Lam Research
$450.50 /

+0.275 (+0.06%)

LH Labcorp
$226.38 /

-7.65 (-3.27%)

ILMN Illumina
$204.06 /

-1.69 (-0.82%)

GPS Gap
$13.96 /

+0.05 (+0.36%)

DKNG DraftKings
$13.93 /

-0.035 (-0.25%)

COIN Coinbase
$40.27 /

+0.01 (+0.02%)

BDX Becton Dickinson
$249.85 /

+2.38 (+0.96%)

BBY Best Buy
$80.90 /

-0.04 (-0.05%)

ULTA Ulta Beauty
$467.55 /

-4.16 (-0.88%)

UA Under Armour
$8.60 /

+0.245 (+2.93%)

TPR Tapestry
$36.60 /

+0.2 (+0.55%)

RGLD Royal Gold
$108.65 /

-1.97 (-1.78%)

QCOM Qualcomm
$117.64 /

-1.4 (-1.18%)

MU Micron
$53.87 /

-1 (-1.82%)

LRCX Lam Research
$450.50 /

+0.275 (+0.06%)

LH Labcorp
$226.38 /

-7.65 (-3.27%)

ILMN Illumina
$204.06 /

-1.69 (-0.82%)

GPS Gap
$13.96 /

+0.05 (+0.36%)

DKNG DraftKings
$13.93 /

-0.035 (-0.25%)

COIN Coinbase
$40.27 /

+0.01 (+0.02%)

BDX Becton Dickinson
$249.85 /

+2.38 (+0.96%)

BBY Best Buy
$80.90 /

-0.04 (-0.05%)

ULTA Ulta Beauty
$467.55 /

-4.16 (-0.88%)

UAA Under Armour
$9.85 /

+0.32 (+3.36%)

TPR Tapestry
$36.60 /

+0.2 (+0.55%)

QCOM Qualcomm
$117.64 /

-1.4 (-1.18%)

MU Micron
$53.87 /

-1 (-1.82%)

LRCX Lam Research
$450.50 /

+0.275 (+0.06%)

ILMN Illumina
$204.06 /

-1.69 (-0.82%)

GPS Gap
$13.96 /

+0.05 (+0.36%)

DKNG DraftKings
$13.93 /

-0.035 (-0.25%)

COIN Coinbase
$40.27 /

+0.01 (+0.02%)

BDX Becton Dickinson
$249.85 /

+2.38 (+0.96%)

BBY Best Buy
$80.90 /

-0.04 (-0.05%)

Downgrade
Ulta Beauty downgraded to Neutral from Buy at Goldman Sachs » 04:50
12/12/22
12/12
04:50
12/12/22
04:50
ULTA

Ulta Beauty

$471.60 /

-9.76 (-2.03%)

Goldman Sachs analyst…

Goldman Sachs analyst Kate McShane downgraded Ulta Beauty to Neutral from Buy with a price target of $508, down from $511. The company's market share gains from here are likely to be "more limited" and it faces difficult year-over-year compares following a strong 2022, McShane tells investors in a research note. In addition, Ulta's margin risk "skews to the downside" given a high level of investing next year and its current valuation suggests limited upside, says the analyst.

ShowHide Related Items >><<
ULTA Ulta Beauty
$471.60 /

-9.76 (-2.03%)

ULTA Ulta Beauty
$471.60 /

-9.76 (-2.03%)

12/05/22 Barclays
Ulta Beauty price target raised to $548 from $511 at Barclays
12/02/22 DA Davidson
Ulta Beauty price target raised to $545 from $490 at DA Davidson
12/02/22 Deutsche Bank
Ulta Beauty price target raised to $607 from $589 at Deutsche Bank
12/02/22 Baird
Ulta Beauty price target raised to $550 from $500 at Baird
ULTA Ulta Beauty
$471.60 /

-9.76 (-2.03%)

ULTA Ulta Beauty
$471.60 /

-9.76 (-2.03%)

ULTA Ulta Beauty
$471.60 /

-9.76 (-2.03%)

Hot Stocks
Ulta Beauty CEO: Consumer is loving what we are offering » 18:25
12/05/22
12/05
18:25
12/05/22
18:25
ULTA

Ulta Beauty

$472.42 /

+0.865 (+0.18%)

In an interview on…

In an interview on CNBC's Mad Money, Dave Kimbell said Ulta saw broad based strength across the business in Q3. The company's positive culture is holding it together and attracting new talent, Kimball said. "We are staffed and ready to go for the holiday season." Ulta continues to bring in new customers and reactivate old ones, with Gen Z representing a strong growth opportunity, Kimbell noted.

ShowHide Related Items >><<
ULTA Ulta Beauty
$472.42 /

+0.865 (+0.18%)

ULTA Ulta Beauty
$472.42 /

+0.865 (+0.18%)

12/05/22 Barclays
Ulta Beauty price target raised to $548 from $511 at Barclays
12/02/22 DA Davidson
Ulta Beauty price target raised to $545 from $490 at DA Davidson
12/02/22 Deutsche Bank
Ulta Beauty price target raised to $607 from $589 at Deutsche Bank
12/02/22 Baird
Ulta Beauty price target raised to $550 from $500 at Baird
ULTA Ulta Beauty
$472.42 /

+0.865 (+0.18%)

ULTA Ulta Beauty
$472.42 /

+0.865 (+0.18%)

ULTA Ulta Beauty
$472.42 /

+0.865 (+0.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.